EMILY FRY: Open Payments
NPI 1578956223 · LITTLE ROCK, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$931 in 62 payments from 13 companies in 2025. Trend: 2023 $526 · 2024 $783 · 2025 $931
Food & beverage: $931
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $220 |
| Currax Pharmaceuticals LLC | 17 | $164 |
| Novo Nordisk Inc | 12 | $160 |
| PFIZER INC. | 5 | $91 |
| AstraZeneca Pharmaceuticals LP | 5 | $90 |
| Phathom Pharmaceuticals, Inc. | 2 | $37 |
| Dexcom, Inc. | 2 | $34 |
| Lilly USA, LLC | 2 | $29 |
| SANOFI-AVENTIS U.S. LLC | 1 | $28 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $26 |
Products named: QULIPTA, ONZETRA XSAIL, NURTEC ODT, Wegovy, AIRSUPRA, UBRELVY, VOQUEZNA, Dexcom G6 Transmitter.
Industry payments across AR — which companies pay providers there.
